Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Public ClinicalTrials.gov record NCT05703971. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2 Clinical Trial of Quaratusugene Ozeplasmid and Atezolizumab Maintenance Therapy in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This clinical trial will evaluate the combination of quaratusugene ozeplasmid with atezolizumab as maintenance therapy for patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC). The study is comprised of 2 phases, a dose selection phase (Phase 1) and a safety and efficacy evaluation phase (Phase 2).
Study identification
- NCT ID
- NCT05703971
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 8, 2024
- Primary completion
- Nov 30, 2027
- Completion
- May 31, 2028
- Last update posted
- Sep 10, 2026
2024 – 2028
United States locations
- U.S. sites
- 17
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rocky Mountain Cancer Centers, LLP | Lone Tree | Colorado | 80124 | Recruiting |
| Washington University School of Medicine - Siteman Cancer Center | St Louis | Missouri | 63110 | Recruiting |
| Gabrail Cancer Center Research | Canton | Ohio | 44718 | Recruiting |
| Oncology_Hematology Care Clinical Trials, LLC | Cincinnati | Ohio | 45211 | Recruiting |
| Oncology_Hematology Care Clinical Trials, LLC | Cincinnati | Ohio | 45236 | Recruiting |
| Oncology_Hematology Care Clinical Trials, LLC | Cincinnati | Ohio | 45242 | Recruiting |
| Oncology_Hematology Care Clinical Trials, LLC | Cincinnati | Ohio | 45245 | Recruiting |
| Oncology_Hematology Care Clinical Trials, LLC | Fairfield | Ohio | 45014 | Recruiting |
| Willamette Valley Cancer Institute (Oregon) | Eugene | Oregon | 97401 | Recruiting |
| Northwest Cancer Specialists, P.C. | Portland | Oregon | 97213-2982 | Recruiting |
| Providence Cancer Institute | Portland | Oregon | 97213 | Recruiting |
| Northwest Cancer Specialists, P.C. | Portland | Oregon | 97227 | Recruiting |
| Northwest Cancer Specialists, P.C. | Tigard | Oregon | 97223 | Recruiting |
| Texas Oncology - DFW | Dallas | Texas | 75246 | Recruiting |
| Texas Oncology - Northeast Texas | Tyler | Texas | 75702 | Recruiting |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | Recruiting |
| Northwest Cancer Specialists, P.C. | Vancouver | Washington | 98684 | Terminated |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05703971, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 10, 2026 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05703971 live on ClinicalTrials.gov.